Please login to the form below

Are you ready for the digital health revolution?

In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age.

Healthcare is in the midst of a paradigm shift. The COVID‑19 pandemic accelerated the adoption of digital technology, driving seismic changes to the care pathway. As the virus took hold, we witnessed a single moment in time when the entire stakeholder ecosystem came together to forge a path for digitalization—an essential strategy for containing the virus. In a matter of months, we plunged into a new digital age.

With vaccines and new treatments providing light at the end of the tunnel, the question now is whether the remote solutions that got us through the pandemic are here to stay, and if so, in what capacity?

In this edition of Delta magazine, we explore the impact of the rapid digitalization of healthcare on the care pathway and uncover what this means for life science companies.

We interview industry leading experts, CEOs, venture capitalists, patient and customer engagement experts and more, to uncover the changing landscape.

Download the magazine to explore: 

  1. The rise of the healthcare social media influencer
  2. The growing trend of hospitals without walls
  3. How AI is revolutionizing clinical trial recruitment
  4. The art of digital storytelling for medical affairs
  5. How you can crack the virtual congress code
  6. Innovations in omnichannel launch excellence
  7. How healthcare tech could be the secret to value-based care

DOWNLOAD THE MAGAZINE HERE

22nd April 2021

Share

Tags

Company Details

Fishawack Health

+44 20 3328 1840

Contact Website

Address:
No. 3 Booths Park
Booths Hall
Chelford Road
Knutsford
Cheshire
WA16 8GS
United Kingdom

Latest content on this profile

Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at PRMA Consulting, a member of Fishawack Health, reveals her advice for developing a successful strategy that meets the needs of every stakeholder.
Fishawack Health
Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)
Fishawack Health announces its expanded global Value, Evidence, and Access (VEA) capability for biopharmaceutical and medical technology companies, with a suite of end-to-end services spanning product lifecycle, coupled with unsurpassed geographic reach.
Fishawack Health
What’s the top trend uniting patients, healthcare professionals, and payers? The desire for a connected customer experience
Milo Elmir, Managing Consultant, examines the trends changing the behaviors of 3 healthcare stakeholders—patients, payers, and healthcare professionals—and explores how building human-centered solutions will help biopharmaceutical and medical technology companies drive better engagement.
Fishawack Health
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline.
Fishawack Health
How to innovate and influence people in times of misinformation
The pandemic has shown that public trust in promising new medical technologies is far from a given. Senior Writer Tom Vandyck at StoneArch, a member of Fishawack delves into the right approach to help companies with breakthrough innovations in their pipeline build consumer confidence.
Fishawack Health
Fishawack Health welcomes expert-led dermatology initiative FIDE to its group
Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology
Fishawack Health